In order to provide further evidence of the efficacy of TBN for the treatment of AD, we conducted further evaluations of the anti-AD effects and the potential mechanisms of action in Aβ reduction by TBN in APP/PS1 mice in vivo and in N2a/APP695swe cells in vitro. Here, APP is linked to Alzheimer disease.